Across TCGA pan-cancer cohorts, MBL3P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MBL3P data layer.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher MBL3P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MBL3P expression acts as an unfavorable survival marker, although some lineages such as LGG and ACC show a favorable association.
READ, DLBC, and MESO are the cancer types where MBL3P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.